LYRA Lyra Therapeutics
- 0.216
- +0.001+0.56%
Lyra Therapeutics News
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0%),Point72 Capital Advisors, Inc.(0%), etc.
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samsara BioCapital, L.P.(4.98%),Samsara BioCapital GP, LLC(4.98%), etc.
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(1.8%),VHCP Co-Investment Holdings II, LLC(1.8%), etc.
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vestal Point Capital, LP(0%),Ryan Wilder(0%)
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Palasis Maria
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cavalier Jason
Lyra Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(19.5%),Joseph Edelman(19.5%), etc.
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ALTMAN MICHAEL SETH
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Poukalov Konstantin
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TOBIN JAMES R
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director snyderman nancy lynn MD
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith W Bradford
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MERRIFIELD C ANN
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waksal Harlan
Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Palasis Maria
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.999%),VHCP Co-Investment Holdings II, LLC(9.999%), etc.
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(7.9%),Citadel Advisors Holdings LP(7.9%), etc.
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%), etc.
Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(8.9%),Wilmot B. Harkey(8.9%), etc.
Lyra Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(24.3%),Joseph Edelman(24.3%), etc.
No Data